MARKET

KOD

KOD

Kodiak Sciences Inc.
NASDAQ
3.770
-0.230
-5.75%
After Hours: 3.950 +0.18 +4.77% 16:55 05/09 EDT
OPEN
3.990
PREV CLOSE
4.000
HIGH
4.159
LOW
3.745
VOLUME
257.13K
TURNOVER
--
52 WEEK HIGH
11.60
52 WEEK LOW
1.920
MARKET CAP
198.92M
P/E (TTM)
-1.1250
1D
5D
1M
3M
1Y
5Y
1D
Kodiak Sciences Inc <KOD.OQ> expected to post a loss of 89 cents a share - Earnings Preview
Reuters · 10h ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 3d ago
Tuesday Sector Laggards: Biotechnology, Drugs
NASDAQ · 3d ago
Weekly Report: what happened at KOD last week (0428-0502)?
Weekly Report · 4d ago
Weekly Report: what happened at KOD last week (0421-0425)?
Weekly Report · 04/28 11:44
Weekly Report: what happened at KOD last week (0414-0418)?
Weekly Report · 04/21 11:44
Weekly Report: what happened at KOD last week (0407-0411)?
Weekly Report · 04/14 11:32
Weekly Report: what happened at KOD last week (0331-0404)?
Weekly Report · 04/07 11:31
More
About KOD
More
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab tedromer, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy and wet age-related macular degeneration. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate designed to inhibit interleukin-6 (IL-6)-mediated inflammation and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.
Recently
Symbol
Price
%Change

Webull offers Kodiak Sciences Inc stock information, including NASDAQ: KOD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KOD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KOD stock methods without spending real money on the virtual paper trading platform.